References

Abele, Niklas, Katharina Tiemann, Till Krech, Axel Wellmann, Christian Schaaf, Florian Langer, Anja Peters, et al. 2023. “Noninferiority of Artificial Intelligence-Assisted Analysis of Ki-67 and Estrogen/Progesterone Receptor in Breast Cancer Routine Diagnostics.” Modern Pathology 36 (2): 100033. https://doi.org/10.1016/j.modpat.2022.100033.

Acs, Balazs, Irma Fredriksson, Caroline Rönnlund, Catharina Hagerling, Anna Ehinger, Anikó Kovács, Rasmus Røge, Jonas Bergh, and Johan Hartman. 2021. “Variability in Breast Cancer Biomarker Assessment and the Effect on Oncological Treatment Decisions: A Nationwide 5-Year Population-Based Study.” Cancers 13 (5): 1166. https://doi.org/10.3390/cancers13051166.

Ahn, Joon Seok, Sunho Shin, Sun Ah Yang, Eun Kyung Park, Kyung Hee Kim, Sun-Il Cho, Jun Won Lee, et al. 2023. “Artificial Intelligence in Breast Cancer Diagnosis and Personalized Medicine.” Journal of Breast Cancer 26 (5): 405–35. https://doi.org/10.4048/jbc.2023.26.e45.

Albuquerque, Daniel Arruda Navarro, Matheus Trotta Vianna, Andrei Vasiliu, Eduardo Henrique Cunha Neves Filho, and Luana Alencar Fernandes Sampaio. 2025. “Systematic Review and Meta-Analysis of Artificial Intelligence in Classifying HER2 Status in Breast Cancer Immunohistochemistry.” Npj Digital Medicine 8 (1): 144. https://doi.org/10.1038/s41746-025-01483-8.

Balci, Serdar. 2022. ClinicoPath Jamovi Module. https://doi.org/10.5281/zenodo.3997188.

Baxi, Vipul, Robin Edwards, Michael Montalto, and Saurabh Saha. 2022. “Digital Pathology and Artificial Intelligence in Translational Medicine and Clinical Practice.” Modern Pathology 35 (1): 23–32. https://doi.org/10.1038/s41379-021-00919-2.

Begum, M Suriya, and S Kalaivani. 2025. “Smart Neural Network and Cognitive Computing Process for Multi Task Nuclei Detection Segmentation and Classification in Breast Cancer Histopathology Images.” Scientific Reports 15 (1): 18435. https://doi.org/10.1038/s41598-025-02575-x.

Campanella, Gabriele, Matthew G Hanna, Luke Geneslaw, Allen Miraflor, Vitor Werneck Krauss Silva, Klaus J Busam, Edi Brogi, Victor E Reuter, David S Klimstra, and Thomas J Fuchs. 2019. “Clinical-Grade Computational Pathology Using Weakly Supervised Deep Learning on Whole Slide Images.” Nature Medicine 25 (8): 1301–9. https://doi.org/10.1038/s41591-019-0508-1.

Chan, Rachel C, Clare KC To, Kenneth CT Cheng, Taniyama Yoshikazu, Lisa LA Yan, Ivan KH Poon, Brandt KH Law, Josephine MN Chan, and Gary M Tse. 2023. “Artificial Intelligence in Breast Cancer Histopathology.” Histopathology 82 (1): 198–210. https://doi.org/10.1111/his.14820.

Choi, Songmi, Jong Hyeok Lee, Hyejin Park, Yul Ri Jung, and Seokhwi Cho. 2024. “Digital Validation in Breast Cancer Needle Biopsies: Comparison of Histological Grade and Biomarker Expression Assessment Using CLM, WSI, and DIA.” Journal of Personalized Medicine 14 (3): 312. https://doi.org/10.3390/jpm14030312.

Corredor, Germán, Satvika Bharadwaj, Tilak Pathak, Vidya Sankar Viswanathan, Paula Toro, and Anant Madabhushi. 2023. “A Review of AI-Based Radiomics and Computational Pathology Approaches in Triple-Negative Breast Cancer: Current Applications and Perspectives.” Clinical Breast Cancer 23 (8): 800–812. https://doi.org/10.1016/j.clbc.2023.06.004.

Datwani, Sneha, Hikmat Khan, Muhammad Khalid Khan Niazi, Anil V Parwani, and Zaibo Li. 2025. “Artificial Intelligence in Breast Pathology: Overview and Recent Updates.” Human Pathology. https://doi.org/10.1016/j.humpath.2025.105819.

Dawe, Melanie, Wei Shi, Tzu-Yun Liu, Katarzyna Lajkosz, Yuki Shibahara, Dimitri Androutsos, Anthony Fyles, Fei-Fei Liu, Susan J Done, and April Khademi. 2024. “Reliability and Variability of Ki-67 Digital Image Analysis Methods for Clinical Diagnostics in Breast Cancer.” Laboratory Investigation 104 (5): 100341. https://doi.org/10.1016/j.labinv.2024.100341.

Dy, Amanda, Ngoc-Nhu Jennifer Nguyen, Julien Meyer, Melanie Dawe, Wei Shi, Dimitri Androutsos, Anthony Fyles, Fei-Fei Liu, Susan Done, and April Khademi. 2024. “AI Improves Accuracy, Agreement and Efficiency of Pathologists for Ki67 Assessments in Breast Cancer.” Scientific Reports 14 (1): 1283. https://doi.org/10.1038/s41598-024-51723-2.

Eren, Oğuzhan Can, Onur Can Taşkın, Murat Oktay, Ahmet Baygül, Fatma Aktepe, Fadime Gül Salman, and Cengiz Yarık. 2026. “Interobserver and Interassay Concordance in HER2 Immunohistochemistry: Implications on HER2-Low Breast Cancer.” Applied Immunohistochemistry & Molecular Morphology 34 (2): 75–81. https://doi.org/10.1097/PAI.0000000000001281.

Gown, Allen M. 2023. “The Biomarker Ki-67: Promise, Potential, and Problems in Breast Cancer.” Applied Immunohistochemistry & Molecular Morphology 31 (4): 221–29. https://doi.org/10.1097/PAI.0000000000001087.

Hamann, Marianne, Matthias Christgen, Oleg Gluz, Ulrike Nitz, Sherko Kümmel, Toralf Reimer, Bahriye Aktas, et al. 2025. “Endocrine Response Assessment in HR-Positive HER2-Negative Early Breast Cancer: Concordance of Local Versus Central Ki67 Measurements in the WSG ADAPTcycle Trial (n = 5292).” ESMO Open 10 (2): 105552. https://doi.org/10.1016/j.esmoop.2025.105552.

Hou, Yu, Hiroaki Nitta, and Zaibo Li. 2023. “HER2 Intratumoral Heterogeneity in Breast Cancer, an Evolving Concept.” Cancers 15 (10): 2664. https://doi.org/10.3390/cancers15102664.

Ibrahim, Asmaa, Paul Gamble, Ronnachai Jaroensri, Mohammed M Abdelsamea, Craig H Mermel, Po-Hsuan Cameron Chen, and Emad A Rakha. 2020. “Artificial Intelligence in Digital Breast Pathology: Techniques and Applications.” The Breast 49: 267–73. https://doi.org/10.1016/j.breast.2019.12.007.

Ibrahim, Asmaa, Ayat Lashen, Michael Toss, Raluca Mihai, and Emad Rakha. 2022. “Assessment of Mitotic Activity in Breast Cancer: Revisited in the Digital Pathology Era.” Journal of Clinical Pathology 75 (6): 365–72. https://doi.org/10.1136/jclinpath-2021-207742.

Ivanova, Mariya, Francesca Maria Porta, Mariia D’Ercole, Carlo Pescia, Elham Sajjadi, Oriana Pala, Giovanni Mazzarol, et al. 2024. “Standardized Pathology Report for HER2 Testing in Compliance with 2023 ASCO/CAP Updates and 2023 ESMO Consensus Statements on HER2-Low Breast Cancer.” Virchows Archiv 483 (5): 885–95. https://doi.org/10.1007/s00428-023-03656-w.

Jung, Minsun, Seung Geun Song, Soo Ick Cho, Sangwon Shin, Taebum Lee, Wonkyung Jung, Hajin Lee, et al. 2024. “Augmented Interpretation of HER2, ER, and PR in Breast Cancer by Artificial Intelligence Analyzer: Enhancing Interobserver Agreement Through a Reader Study of 201 Cases.” Breast Cancer Research 26 (1): 31. https://doi.org/10.1186/s13058-024-01784-y.

Krishnamurthy, Savitri, Armin Salajegheh, Jesse Engel, William Greaves, Tina Kimbrough, Steven P Naber, Paula S Ginter, et al. 2024. “Fully Automated Artificial Intelligence Solution for Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Scoring in Breast Cancer: A Multireader Study.” JCO Precision Oncology 8: e2400353. https://doi.org/10.1200/PO.24.00353.

Li, Lina, Dandan Han, Yongqiang Yu, Jinze Li, and Yueping Liu. 2022. “Artificial Intelligence-Assisted Interpretation of Ki-67 Expression and Repeatability in Breast Cancer.” Diagnostic Pathology 17 (1): 20. https://doi.org/10.1186/s13000-022-01196-6.

Li, Wei, Shuang Ye, Zhongyi Jin, Lin Chen, Yue Chao, and Kun Qian. 2025. “Artificial Intelligence in Digital Pathology of Breast Cancer, New Era of Practice?” International Journal of Surgery. https://doi.org/10.1097/JS9.0000000000002953.

Liao, Chiu-Hsiang Connie, Nilay Bakoglu, Emine Cesmecioglu, Matthew Hanna, Fresia Pareja, Hannah Y Wen, Timothy M D’Alfonso, Edi Brogi, Yukako Yagi, and Dara S Ross. 2024. “Semi-Automated Analysis of HER2 Immunohistochemistry in Invasive Breast Carcinoma Using Whole Slide Images: Utility for Interpretation in Clinical Practice.” Pathology & Oncology Research 30: 1611826. https://doi.org/10.3389/pore.2024.1611826.

Liu, Yueping, Dandan Han, Anil V Parwani, and Zaibo Li. 2023. “Applications of Artificial Intelligence in Breast Pathology.” Archives of Pathology & Laboratory Medicine 147 (9): 1003–13. https://doi.org/10.5858/arpa.2022-0457-RA.

Niazi, Muhammad Khalid Khan, Anil V Parwani, and Metin N Gurcan. 2019. “Digital Pathology and Artificial Intelligence.” The Lancet Oncology 20 (5): e253–61. https://doi.org/10.1016/S1470-2045(19)30154-8.

Ottl, Sandra, Romain Mormont, Martı́n Cardoso, Hussam Jaafar, Olivier Mounie, Viktor H Kölzer, and Jens Behrmann. 2025. “Fully Automatic HER2 Tissue Segmentation for Interpretable HER2 Scoring.” Journal of Pathology Informatics 16: 100425. https://doi.org/10.1016/j.jpi.2024.100425.

Palm, Christiane, Catherine E Connolly, Regina Masser, Barbara Padberg Sgier, Eva Karamitopoulou, Quentin Simon, Beata Bode, and Marianne Tinguely. 2023. “Determining HER2 Status by Artificial Intelligence: An Investigation of Primary, Metastatic, and HER2 Low Breast Tumors.” Diagnostics 13 (1): 168. https://doi.org/10.3390/diagnostics13010168.

Parry, Suzanne, Stephen B Fox, Glenn D Francis, Jane E Armes, Ryan Carpenter, Cheok Soon Chan, Beng Huat Chua, et al. 2025. “Inter-Rater Agreement of HER2-Low Scores Between Expert Breast Pathologists and the Visiopharm Digital Image Analysis Application.” The Journal of Pathology: Clinical Research 11 (3): e70051. https://doi.org/10.1002/2056-4538.70051.

R Core Team. 2024. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. https://www.R-project.org/.

Reis-Filho, Jorge S, and Jakob Nikolas Kather. 2023. “Overcoming the Challenges to Implementation of Artificial Intelligence in Pathology.” Journal of the National Cancer Institute 115 (6): 608–12. https://doi.org/10.1093/jnci/djad048.

Rotondi, Michael A. 2022. kappaSize: Sample Size Estimation Functions for Studies of Interobserver Agreement. https://cran.r-project.org/web/packages/kappaSize/.

Shafi, Saba, David A Kellough, Giovanni Lujan, Swati Satturwar, Anil V Parwani, and Zaibo Li. 2022. “Integrating and Validating Automated Digital Imaging Analysis of Estrogen Receptor Immunohistochemistry in a Fully Digital Workflow for Clinical Use.” Journal of Pathology Informatics 13: 100122. https://doi.org/10.1016/j.jpi.2022.100122.

Shamai, Gil, Avihai Livne, António Polónia, Edmond Sabo, Anca Cretu, Gil Bar-Sela, and Ron Kimmel. 2022. “Deep Learning-Based Image Analysis Predicts PD-L1 Status from h&e-Stained Histopathology Images in Breast Cancer.” Nature Communications 13 (1): 6753. https://doi.org/10.1038/s41467-022-34275-9.

Soliman, Amr, Zaibo Li, and Anil V Parwani. 2024. “Artificial Intelligence’s Impact on Breast Cancer Pathology: A Literature Review.” Diagnostic Pathology 19 (1): 38. https://doi.org/10.1186/s13000-024-01453-w.

Tan-Garcia, Alexis, Tien Huey Chua, and Wei Qiang Leow. 2025. “Computational Pathology in the Age of Artificial Intelligence - Embrace Not Fear.” The Journal of Pathology: Clinical Research. https://doi.org/10.1002/2056-4538.70049.

The jamovi project. 2024. Jamovi. https://www.jamovi.org.

Thomson, Thomas A, Malcolm M Hayes, John J Spinelli, Ernie Hilland, Christina Sawrenko, Don Phillips, Beverley Dupuis, and Robin L Parker. 2001. “HER-2/Neu in Breast Cancer: Interobserver Variability and Performance of Immunohistochemistry with 4 Antibodies Compared with Fluorescent in Situ Hybridization.” Modern Pathology 14 (11): 1079–86. https://doi.org/10.1038/modpathol.3880440.

Wang, Yinxi, Balázs Acs, Stephen Robertson, Bo Liu, Lucı́a Solorzano, Carolina Wählby, Johan Hartman, and Mattias Rantalainen. 2022. “Improved Breast Cancer Histological Grading Using Deep Learning.” Annals of Oncology 33 (1): 89–98. https://doi.org/10.1016/j.annonc.2021.09.007.

Wu, Si, Meng Yue, Jun Zhang, Xiaoxian Li, Zaibo Li, Huina Zhang, Xinran Wang, et al. 2023. “The Role of Artificial Intelligence in Accurate Interpretation of HER2 Immunohistochemical Scores 0 and 1+ in Breast Cancer.” Modern Pathology 36 (3): 100054. https://doi.org/10.1016/j.modpat.2022.100054.

Xiao, Wenzhao, Paula S Ginter, Aniruddha Bhattacharyya, Jordan P Reynolds, Maulik Gajjar, Melissa P Murray, Hannah Y Wen, Edi Brogi, and Dara S Ross. 2025. “Comparative Study of Intra- and Inter-Observer Variability in Manual Scoring of HER2 IHC Stains on Glass Slides Versus Paired Digital Images.” Human Pathology 161: 105860. https://doi.org/10.1016/j.humpath.2025.105860.

Yan, Shiyun, Jingjing Li, and Wenzhe Wu. 2023. “Artificial Intelligence in Breast Cancer: Application and Future Perspectives.” Journal of Cancer Research and Clinical Oncology 149 (18): 16879–96. https://doi.org/10.1007/s00432-023-05337-2.

Zilenaite-Petrulaitiene, Dovile, Birute Stankeviciene, Allan Rasmusson, and Arvydas Laurinavicius. 2025. “Reproducibility of Ki67 Haralick Entropy as a Prognostic Marker in ER+/HER2- Breast Cancer.” American Journal of Clinical Pathology, aqaf081. https://doi.org/10.1093/ajcp/aqaf081.